ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart transplant patients"

  • 2017 American Transplant Congress

    Antibody Mediated Rejection and Donor Specific Antibodies in Heart Transplant Patients: Single Center Experience.

    P. McMullen II,1 J. Xin,1 N. Brown,1 R. Upchurch,1 J. Weidner,1 S. Fedson,2 A. Husain,1 S. Marino.1

    1Pathology, University of Chicago Medicine, Chicago, IL; 2Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX

    BACKGROUND AND AIMS: Preexisting donor specific antibodies (DSA) cause acute antibody mediated rejection (AMR), which can be avoided during pre-transplant work up. Diagnosis and management…
  • 2017 American Transplant Congress

    Is the Current Heart Allocation System Just and Fair for Blood Type O Recipients? – A Propensity-Matched Analysis of 34353 Patients in the UNOS Registry.

    M. Ando, K. Takeda, P. Kurlansky, M. Wright, C. Lee, J. Han, A. Garan, V. Topkara, M. Yuzefpolskaya, P. Colombo, M. Farr, Y. Naka, H. Takayama.

    Columbia University Medical Center, New York, NY

    Purpose: There is a known disparity between the waiting time on heart transplant (HTx) between blood type O and non-O recipients. This difference is mainly…
  • 2017 American Transplant Congress

    Risk of Amiodarone and Permanent Pacemaker Placement After Heart Transplantation.

    E. Kransdorf, M. Kittleson, J. Patel, T. Aintablian, R. Levine, B. Kearney, N. Musto, A. Hage, D. Geft, L. Czer, F. Esmailian, A. Trento, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Background: Patients (pts) with end stage heart disease undergoing heart transplantation (HT) may be on amiodarone (AD) for arrhythmias. AD may persist for weeks after…
  • 2017 American Transplant Congress

    Young African American Heart Transplant Recipients Have an Elevated Risk of Post-Transplant Mortality.

    H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.

    JHU, Baltimore

    African American (AA) race is associated with worse survival among heart transplant recipients. Even after controlling for socioeconomic and clinical characteristics, racial disparities persist and…
  • 2017 American Transplant Congress

    Post-Transplant Sensitization: Does it Make a Difference in the Development of First-Year Intimal Thickening?

    J. Patel, M. Kittleson, L. Czer, T. Aintablian, E. Stimpson, B. Azarbal, D. Geft, D. Chang, F. Esmailian, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Background: The development of donor specific antibody (DSA) after heart transplantation has been reported to be associated with the development of cardiac allograft vasculopathy (CAV).…
  • 2017 American Transplant Congress

    High Titer De Novo Donor-Specific HLA Alloantibodies and Cardiac Allograft Vasculopathy After Pediatric Heart Transplantation.

    B. Das,1 S. Zhang,2 A. Gao,2 C. Lacelle.3

    1Division of Cardiology, Dept. of Pediatrics, UTSW Medical Center, Dallas, TX; 2Department of Clinical Science Research, UTSW Medical Center, Dallas, TX; 3Department of Pathology, UTSW Medical Center, Dallas, TX

    Background: Cardiac allograft vasculopathy (CAV) continues to be a limiting factor in long-term survival after pediatric heart transplantation (HT). Criteria for early diagnosis of CAV…
  • 2017 American Transplant Congress

    Severe Tricuspid Regurgitation After Heart Transplantation: Does It Require Surgical Repair?

    J. Patel, M. Kittleson, L. Czer, T. Aintablian, R. Sharoff, R. Levine, A. Velleca, D. Ramzy, F. Esmailian, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Background: Tricuspid regurgitation (TR) after heart transplantation is common. Causes for TR may be due to volume overload, flail tricuspid leaflet from endomyocardial biopsy, pulmonary…
  • 2017 American Transplant Congress

    Primary Graft Dysfunction After Pediatric Heart Transplant.

    K. Mowers, K. Simpson, P. Eghtesady, O. Petrucci, C. Canter, C. Castleberry.

    Pediatric Cardiology, Washington University School of Medicine, St. Louis, MO

    Background: Primary graft dysfunction (PGD), as defined by ISHLT Consensus Guidelines, has been associated with worse outcomes in adult heart transplant recipients, even in patients…
  • 2017 American Transplant Congress

    Improvement of Cyclosporine A Dosing Strategy to Enhance Medication Adherence.

    M. Barten,1 E. Harmel,1 M. Goldmann,1 F. Wagner,1 H. Reichenspurner,1 M. Rybczynski.2

    1Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany; 2General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany

    Background: It is known that the number of daily pills is crucial for medical adherence of patients after heart transplantation (HTx). For cyclosporine A (CsA)…
  • 2017 American Transplant Congress

    Comparing the Role of Post-Transplant Readmissions and Bed Days on Total One Year Cost of Care.

    W. Bannister,1 M. Schnitzler,2 J. Tao,1 A. Bonagura,1 B. Laihinen,1 F. Irwin,1 C. Horstman.1

    1Complex Medical Conditions, Optum, UnitedHealth Group, Eden Prairie, MN; 2Surgery, St. Louis University, St. Louis, MO

    This study examines the marginal impact of readmissions and total bed days during the 90-day period following transplant in order to better understand drivers of…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences